NexGel (NXGL) versus Its Peers Head to Head Review

NexGel (NASDAQ:NXGL) is one of 511 publicly-traded companies in the “Healthcare Equipment & Supplies” industry, but how does it weigh in compared to its peers? We will compare NexGel to similar businesses based on the strength of its earnings, risk, analyst recommendations, valuation, institutional ownership, profitability and dividends.

Profitability

This table compares NexGel and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
NexGel	-51.26%	-121.18%	-41.15%
NexGel Competitors	-278.38%	-150.31%	-21.96%

Volatility & Risk

NexGel has a beta of 0.82, meaning that its share price is 18% less volatile than the S&P 500. Comparatively, NexGel’s peers have a beta of 2.56, meaning that their average share price is 156% more volatile than the S&P 500.

Valuation and Earnings

This table compares NexGel and its peers revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
NexGel	$12.07 million	-$3.00 million	-0.28
NexGel Competitors	$1.89 billion	$138.79 million	11.13

NexGel’s peers have higher revenue and earnings than NexGel. NexGel is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Insider and Institutional Ownership

2.2% of NexGel shares are owned by institutional investors. Comparatively, 40.5% of shares of all “Healthcare Equipment & Supplies” companies are owned by institutional investors. 19.8% of NexGel shares are owned by company insiders. Comparatively, 14.8% of shares of all “Healthcare Equipment & Supplies” companies are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for NexGel and its peers, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NexGel	1	2	0	0	1.67
NexGel Competitors	4243	10460	18171	820	2.46

NexGel currently has a consensus target price of $40.00, indicating a potential upside of 915.23%. As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 22.27%. Given NexGel’s higher probable upside, analysts clearly believe NexGel is more favorable than its peers.

Summary

NexGel peers beat NexGel on 9 of the 13 factors compared.

About NexGel

NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. The company was incorporated in 2009 and is based in Langhorne, Pennsylvania.